Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urinary Bladder Neoplasms × Interleukin-15 × Clear all

Sponsor

Conditions

Sezary Syndrome 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Thyroid Neoplasms 1 Skin Neoplasms 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Lung Neoplasms 1 Leukemia-Lymphoma, Adult T-Cell 1 Leukemia, Prolymphocytic, T-Cell 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma 1 Bronchiolitis Obliterans Syndrome 1 Breast Neoplasms 1

Interventions

Gemcitabine 42 Cisplatin 29 pembrolizumab 25 Paclitaxel 12 Docetaxel 12 atezolizumab 11 Nivolumab 10 Mitomycin 10 avelumab 9 Carboplatin 9 Cystectomy 8 durvalumab 7 Sunitinib 7 Doxorubicin 6 BCG Vaccine 6 5-aminolevulinic acid hexyl ester 6 apaziquone 5 Vinblastine 5 Platinum 5 Methotrexate 5 Albumin-Bound Paclitaxel 5 Taxes 4 Standard of Care 4 Radiotherapy 4 Radiation 4 Fluorouracil 4 Erlotinib Hydrochloride 4 1,2-diaminocyclohexaneplatinum II citrate 4 vinflunine 3 tisotumab vedotin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡